BiotechTube
Home/General Oncology/Jeff Glazier
JG

Jeff Glazier

Chief Executive Officer

General Oncology

Therapeutic Areas

OncologyOphthalmology

General Oncology Pipeline

DrugIndicationPhase
GO-4305CMetastatic cancers, including BRCA-associated pancreatic ductal adenocarcinomaPhase 1
GO-2301Wet age-related macular degeneration (AMD) and diabetic retinopathyPreclinical

Leadership Team at General Oncology

AG
Arnold Glazier, M.D.
Chief Scientific Officer
AA
Abid Ansari
Chief Financial Officer
HD
Hongbo Deng, Ph.D.
Vice President of Medicinal Chemistry
View full General Oncology profile